Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome–Coronavirus 2 In Vitro When Administered After Virus Infection

The ongoing coronavirus disease 2019 pandemic has forced the clinical and scientific community to try drug repurposing of existing antiviral agents as a quick option against severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2). Under this scenario, interferon (IFN) β-1a, whose antiviral pote...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Clementi, Nicola, Ferrarese, Roberto, Criscuolo, Elena, Diotti, Roberta Antonia, Castelli, Matteo, Scagnolari, Carolina, Burioni, Roberto, Antonelli, Guido, Clementi, Massimo, Mancini, Nicasio
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7337790/
https://ncbi.nlm.nih.gov/pubmed/32559285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa350
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares